Lorem Ipsum

Lorem Ipsum

Our Team

Seasoned management team of cytometric profiling experts, experienced clinicians, and biotech professionals

Larry Weisenthal, MD, PhD

Chief Science Officer
  • Clinical Associate, Medicine Branch, National Cancer Institute
  • Board Certified: Internal Medicine & Medical Oncology
  • Clinical Professor of Medicine (Hematology/Oncology), U. Cal Irvine School of Medicine
  • 30 years experience directing two California, Medicare, and CLIA licensed clinical oncology labs.
  • MD, PhD (Pharmacology) U. Michigan School of Medicine

William Grace, MD

Chief Medical Officer
  • Research Associate, Experimental Hematology & Immunology, NIH Navy
  • Director Armed Forces Bone Marrow Transplant Program
  • Chief of Cancer Research & Medical Oncology, St. Vincent’s
  • President, New York Cancer Society
  • 5 years Castle Connelly Top Doctor 
  • Notre Dame, BS
  • Boston University, MD

Laurin Cristiano, MD

Director of Research
  • Asst. Prof. of OB-GYN, Loma Linda Univ. School of Medicine 
  • 4 years bench research in cell biology (stem cell) science
  • Former start up biotech researcher, iPierian (acquired by Bristol- Meyers Squibb for $750M) 
  • Harvard, BA, Biochemistry 

William Grace

Chief Operating Officer
  • Co-Founder, COO MDRx Financial, the first comprehensive healthcare data network for financial markets 
  • Co-Founder, COO Good Works Health, the first federal-government approved online marketing platform 
  • BA, Dartmouth College
  • Chairman, Dartmouth Union
  • Editor-in-Chief, Dartmouth Review

Paul Kanan

Chief Executive Officer
  • EVP & CFO Agensy, acquired by Astellas in 2007
  • CEO of Pacific Biometrics: Led company from start-up to successful IPO in 1996 
  • CEO of Oncotech: Joined with Larry Weisenthal in early development of assay assisted drug selection technology for cancer 
  • Division President, Baxter Healthcare 
  • BS Engineering, University of Michigan 
  • MBA, Harvard